Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)

Market Cap	3.66B +66.8%
Revenue (ttm)	339.54M -2.7%
Net Income	16.49M +26.3%
EPS	0.14 +16.7%
Shares Out	119.99M
PE Ratio	217.71
Forward PE	n/a
Dividend	0.10 (0.35%)
Ex-Dividend Date	Sep 25, 2025

Volume	9,096,285
Average Volume	6,150,513
Open	28.20
Previous Close	28.97
Day's Range	28.20 - 30.52
52-Week Range	14.13 - 42.25
Beta	1.48
RSI	63.77
Earnings Date	Mar 27, 2026

About SHE:300813

Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Employees: 797
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300813

Financial Performance

In 2025, SHE:300813's revenue was 339.54 million, a decrease of -2.71% compared to the previous year's 349.00 million. Earnings were 16.49 million, an increase of 26.32%.